Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
{{familytree | | | | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | | | | | | | |E02| | | | | | | | E02=Gender specific tests}} | {{familytree | | | | | | | | | |E02| | | | | | | | E02=Gender specific tests}} | ||
{{familytree | | | | |, | {{familytree | | | | | |,|-|-|-|+|-|-|-|.| | | | }} | ||
{{familytree | | | | | | {{familytree | | | | | |''Male''<br> • PSA <br> •aFP <br> •BHCG | | | | | | | |''Female''<br> • Mammography<br> • Ultrasound or pelvic CT| | | | }} | ||
{{familytree/end}} | {{familytree/end}} |
Revision as of 18:13, 10 October 2018
Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||||||||
• Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||||||||
Histopathologic examination | |||||||||||||||||||||||||||||||||||||||||||
Squamous cell carcinoma | Adenocarcinoma and poorly differntiated carcinoma | Neuroendocrine carcinoma | |||||||||||||||||||||||||||||||||||||||||
Gender specific tests | |||||||||||||||||||||||||||||||||||||||||||
{{{Male • PSA •aFP •BHCG }}} | {{{Female • Mammography • Ultrasound or pelvic CT}}} | ||||||||||||||||||||||||||||||||||||||||||